Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis. Trapnell BC, Inoue Y, Bonella F, Wang T, et al. N Engl J Med 2025;393:764-773.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Trapnell BC, Inoue Y, Bonella F, Wang T, et al. Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis. N Engl J Med 2025;393:764-773.
PMID: 40834301